What are the side effects of Tegoprazan?

Tegoprazan is a relatively new medication used primarily in the treatment of acid-related disorders, including gastroesophageal reflux disease (GERD) and peptic ulcers. As with any medication, understanding the potential side effects of Tegoprazan is crucial for both patients and healthcare providers. While the drug has shown promise in clinical trials due to its efficacy and improved patient tolerability compared to older medications, it is not without its side effects.

Common side effects reported with Tegoprazan use include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. These symptoms are generally mild to moderate and often resolve on their own without the need for medical intervention. However, persistent or severe gastrointestinal symptoms should be reported to a healthcare provider.

In addition to gastrointestinal issues, some patients have reported experiencing headaches while taking Tegoprazan. Headaches are relatively common with many medications and can often be managed with over-the-counter pain relief. Nonetheless, if headaches are severe or do not improve, it is advisable to consult a healthcare professional.

Another potential side effect of Tegoprazan is dizziness. Dizziness can affect daily activities and increase the risk of falls, particularly in older adults. Patients who experience dizziness should avoid activities that require full alertness, such as driving or operating heavy machinery, until they know how the medication affects them.

While less common, some patients may experience allergic reactions to Tegoprazan. Symptoms of an allergic reaction can include rash, itching, swelling, severe dizziness, and difficulty breathing. An allergic reaction is a medical emergency, and immediate medical attention should be sought if any of these symptoms occur.

Tegoprazan can also have effects on blood parameters. Some studies have reported changes in liver function tests, which are typically reversible and return to normal after discontinuation of the drug. Regular monitoring by a healthcare provider may be recommended to ensure that liver function remains within the normal range during treatment.

Moreover, as with any proton pump inhibitor (PPI), long-term use of Tegoprazan may carry additional risks. These can include an increased risk of bone fractures, kidney disease, and vitamin B12 deficiency. It is essential for patients to discuss the duration of their treatment with their healthcare provider to minimize these risks, particularly if they need to use the medication for an extended period.

In summary, while Tegoprazan is generally well-tolerated and effective for treating acid-related disorders, it is important to be aware of its potential side effects. Common issues like gastrointestinal disturbances, headaches, and dizziness are usually manageable, but more serious side effects such as allergic reactions and changes in liver function require prompt medical attention. Long-term users should also be aware of potential risks associated with prolonged use. Patients should maintain open communication with their healthcare provider to ensure safe and effective use of Tegoprazan.